Combining rapid antigen testing and syndromic surveillance improves community-based COVID-19 detection in a low-income country.
Mair, Frances S
Springer Science and Business Media LLC
MetadataShow full item record
Chadwick, F. J., Clark, J., Chowdhury, S., Chowdhury, T., Pascall, D. J., Haddou, Y., Andrecka, J., et al. (2022). Combining rapid antigen testing and syndromic surveillance improves community-based COVID-19 detection in a low-income country.. Nat Commun, 13 (1) https://doi.org/10.1038/s41467-022-30640-w
Diagnostics for COVID-19 detection are limited in many settings. Syndromic surveillance is often the only means to identify cases but lacks specificity. Rapid antigen testing is inexpensive and easy-to-deploy but can lack sensitivity. We examine how combining these approaches can improve surveillance for guiding interventions in low-income communities in Dhaka, Bangladesh. Rapid-antigen-testing with PCR validation was performed on 1172 symptomatically-identified individuals in their homes. Statistical models were fitted to predict PCR-status using rapid-antigen-test results, syndromic data, and their combination. Under contrasting epidemiological scenarios, the models' predictive and classification performance was evaluated. Models combining rapid-antigen-testing and syndromic data yielded equal-to-better performance to rapid-antigen-test-only models across all scenarios with their best performance in the epidemic growth scenario. These results show that drawing on complementary strengths across rapid diagnostics, improves COVID-19 detection, and reduces false-positive and -negative diagnoses to match local requirements; improvements achievable without additional expense, or changes for patients or practitioners.
Humans, Sentinel Surveillance, Models, Statistical, Bangladesh, Epidemics, COVID-19
MRC (via University of Warwick) (MR/V038613/1)
External DOI: https://doi.org/10.1038/s41467-022-30640-w
This record's URL: https://www.repository.cam.ac.uk/handle/1810/338554
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/